• Free Trial
  • Audio & Video Podcasts
  • Student Stories
  • Trade Policy
  • Press Releases
  • Events
  • Contact Us
  • WisPolitics
Search
Saturday, October 18, 2025
  • Home
WisBusiness.com WisBusiness
WisBusiness.com WisBusiness.com
  • Free Trial
  • Audio & Video Podcasts
  • Student Stories
  • Trade Policy
  • Press Releases
  • Events
  • Contact Us
  • WisPolitics
Home News Positive results for Exact Sciences’ Cologuard cancer test boost stock price

Positive results for Exact Sciences’ Cologuard cancer test boost stock price

March 20, 2014
http://host.madison.com/business/positive-results-for-exact-sciences-cologuard-cancer-test-boost-stock/article_0922880b-c256-5a2f-a27c-f0b873535488.html
Facebook
Twitter
Google+
Pinterest
WhatsApp

    RELATED ARTICLESMORE FROM AUTHOR

    Wisconsin companies face $1.5B loss as DOE plans to terminate clean energy project funding

    UW-Madison wants to grow defense research — but not build weapons

    Eli Lilly exec discusses more mega projects, but where?

    - Advertisement -
    • WisBusiness
    Tweets by wisbusiness

    Press Releases

    October 2025
    • October 2025
    MonTueWedThuFriSatSun
      12345
    6789101112
    13141516171819
    20212223242526
    2728293031  
           

    Press Releases

    October 2025
    • October 2025
    MonTueWedThuFriSatSun
      12345
    6789101112
    13141516171819
    20212223242526
    2728293031  
           

    Press Releases

    October 2025
    • October 2025
    MonTueWedThuFriSatSun
      12345
    6789101112
    13141516171819
    20212223242526
    2728293031  
           

    Press Releases

    October 2025
    • October 2025
    MonTueWedThuFriSatSun
      12345
    6789101112
    13141516171819
    20212223242526
    2728293031  
           

    For questions or assistance, please contact: Colin Schmies at schmies@wispolitics.com or 608-206-0476

    WisBusiness.com
    • Subscribe
    • Advertise
    • Press Releases
    • Audio & Video Podcasts
    • RSS
    © 2025 WisBusiness.com All rights reserved.